FDA orders "black box" on antibiotics for tendon risks

07/8/2008 | Wall Street Journal, The · Washington Post, The

"Black box" warnings about the risks of tendon rupture will be added to fluoroquinolones, a class of antibiotics that includes Ortho-McNeil's Levaquin and Bayer AG's Cipro, FDA officials announced. The agency, which was sued by consumer group Public Citizen to push for such labels, said it will ask drugmakers to develop a medication guide to alert patients about potential adverse reactions to their products. Manufacturers said they will comply with the FDA's decision but maintained that their treatments' benefits outweigh the dangers.

View Full Article in:

Wall Street Journal, The · Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA